Halliburton
HAL
31.75
-0.97
-2.96%
Halliburton
US · HAL
#741 by market cap
Listed 1970
31.75
-0.97
-2.96%
Live - 5344 symbols - heartbeat 14s ago
· 2026-10-08 06:09
Pre-market
32.13
+1.20%
After-hours
31.75
0.00%
Overnight
31.84
+0.28%
- Market cap
- 26.45B
- P/E (TTM)i
- 16.62
- P/Bi
- 2.40
- EPSi
- 1.50
- Div yieldi
- 2.14%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on HAL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.51, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.31% YoY
Margins
- Gross margin
- 15.71%
- Operating margin
- 13.93%
- Net margin
- 5.78%
Key ratios & quality
- Enterprise valuei
- 31.67B
- Altman Z-Scorei
- 3.51
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.00B | 22.41B | 14.45B | 15.30B | 20.30B | 23.02B | 22.94B | 22.18B |
| Gross profit | 2.99B | 2.29B | 1.55B | 2.02B | 3.31B | 4.36B | 4.30B | 3.48B |
| Selling & admin expenses | 254.00M | 227.00M | 182.00M | 204.00M | 240.00M | 226.00M | 239.00M | 239.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.73B | 2.06B | 1.36B | 1.78B | 3.07B | 4.08B | 3.94B | 3.09B |
| Pretax profit | 1.81B | -1.12B | -3.22B | 1.25B | 2.11B | 3.36B | 3.23B | 1.77B |
| Tax | 157.00M | 7.00M | -278.00M | -216.00M | 515.00M | 701.00M | 718.00M | 479.00M |
| Net profit | 1.66B | -1.13B | -2.94B | 1.47B | 1.60B | 2.66B | 2.52B | 1.29B |
| Basic EPS | 2 | -1 | -3 | 2 | 2 | 3 | 3 | 2 |
| Diluted EPS | 1.89 | -1.29 | -3.34 | 1.63 | 1.73 | 2.92 | 2.83 | 1.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.42B | 5.51B | 5.60B | 5.66B | 5.40B | 5.71B |
| Gross profit | 879.00M | 819.00M | 856.00M | 930.00M | 783.00M | 804.00M |
| Selling & admin expenses | 62.00M | 60.00M | 58.00M | 59.00M | 62.00M | 75.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 787.00M | 727.00M | 748.00M | 829.00M | 679.00M | 683.00M |
| Pretax profit | 306.00M | 611.00M | 219.00M | 635.00M | 569.00M | 664.00M |
| Tax | 103.00M | 131.00M | 199.00M | 46.00M | 105.00M | 126.00M |
| Net profit | 203.00M | 480.00M | 20.00M | 589.00M | 464.00M | 538.00M |
| Basic EPS | 0 | 1 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.24 | 0.55 | 0.02 | 0.70 | 0.55 | 0.64 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 11.15B | 11.21B | 9.48B | 9.94B | 10.95B | 11.54B | 12.38B | 11.40B |
| Cash & ST investments | 2.01B | 2.27B | 2.56B | 3.04B | 2.35B | 2.26B | 2.62B | 2.21B |
| Inventory | 3.03B | 3.14B | 2.35B | 2.36B | 2.92B | 3.23B | 3.04B | 2.98B |
| Total assets | 25.98B | 25.38B | 20.68B | 22.32B | 23.26B | 24.68B | 25.59B | 25.01B |
| Total current liabilities | 4.80B | 4.88B | 4.42B | 4.31B | 5.35B | 5.61B | 6.05B | 5.59B |
| Short-term debt | -- | 219.00M | 946.00M | 240.00M | 224.00M | 262.00M | 644.00M | 263.00M |
| Long-term debt | 10.31B | 10.32B | 9.13B | 9.13B | 7.93B | 7.64B | 7.16B | 7.16B |
| Total liabilities | 16,438,000,000.00 | 17,352,000,000.00 | 15,697,000,000.00 | 15,593,000,000.00 | 15,278,000,000.00 | 15,250,000,000.00 | 15,039,000,000.00 | 14,505,000,000.00 |
| Total equity | 9.54B | 8.03B | 4.98B | 6.73B | 7.98B | 9.43B | 10.55B | 10.51B |
| Retained earnings | 13.74B | 11.99B | 8.69B | 9.71B | 10.57B | 12.54B | 14.33B | 15.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 11.53B | 11.67B | 11.64B | 11.40B | 11.54B | 11.88B |
| Cash & ST investments | 1.80B | 2.04B | 2.03B | 2.21B | 2.00B | 2.05B |
| Inventory | 3.04B | 3.07B | 3.10B | 2.98B | 3.02B | 3.06B |
| Total assets | 25.18B | 25.38B | 25.16B | 25.01B | 25.14B | 25.83B |
| Total current liabilities | 5.82B | 5.84B | 5.95B | 5.59B | 5.54B | 5.89B |
| Short-term debt | 645.00M | 642.00M | 676.00M | 263.00M | 333.00M | 377.00M |
| Long-term debt | 7.16B | 7.16B | 7.16B | 7.16B | 7.07B | 7.07B |
| Total liabilities | 14,770,000,000.00 | 14,830,000,000.00 | 14,918,000,000.00 | 14,505,000,000.00 | 14,317,000,000.00 | 14,776,000,000.00 |
| Total equity | 10.41B | 10.55B | 10.25B | 10.51B | 10.83B | 11.05B |
| Retained earnings | 14.39B | 14.72B | 14.59B | 15.04B | 15.36B | 15.72B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.16B | 2.45B | 1.88B | 1.91B | 2.24B | 3.46B | 3.87B | 2.93B |
| Depreciation & amortization | 1.61B | 1.63B | 1.06B | 904.00M | 940.00M | 998.00M | 1.08B | 1.14B |
| Free cash flow | 1.13B | 915.00M | 1.15B | 1.11B | 1.23B | 2.08B | 2.42B | 1.67B |
| Dividends paid | -630.00M | -630.00M | -278.00M | -161.00M | -435.00M | -576.00M | -600.00M | -579.00M |
| Stock buybacks / issuance | -205.00M | 18.00M | -13.00M | 79.00M | -21.00M | -664.00M | -900.00M | -909.00M |
| Ending cash balance | 2.01B | 2.27B | 2.56B | 3.04B | 2.35B | 2.26B | 2.62B | 2.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 377.00M | 896.00M | 488.00M | 1.17B | 273.00M | 824.00M |
| Depreciation & amortization | 277.00M | 284.00M | 285.00M | 290.00M | 295.00M | 296.00M |
| Free cash flow | 75.00M | 542.00M | 227.00M | 828.00M | 81.00M | 589.00M |
| Dividends paid | -147.00M | -145.00M | -144.00M | -143.00M | -142.00M | -143.00M |
| Stock buybacks / issuance | -250.00M | -257.00M | -250.00M | -152.00M | -100.00M | -208.00M |
| Ending cash balance | 1.80B | 2.04B | 2.03B | 2.21B | 2.00B | 2.05B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.56 | -12.90 | -45.36 | 24.93 | 21.44 | 30.43 | 25.14 | 12.24 |
| ROA %i | 6.49 | -4.40 | -12.79 | 6.78 | 6.90 | 11.01 | 9.95 | 5.07 |
| ROIC %i | 11.02 | -3.64 | -14.12 | 10.99 | 10.97 | 17.28 | 14.88 | 8.17 |
| 5-year avg ROE %i | -2.76 | -10.03 | -18.25 | -4.00 | 1.34 | 3.71 | 11.32 | 22.84 |
| EBIT margin %i | 10.05 | -2.37 | -18.53 | 11.64 | 12.82 | 17.12 | 16.06 | 9.57 |
| FCF / sales %i | 4.71 | 4.08 | 7.98 | 7.27 | 6.06 | 9.03 | 10.56 | 7.54 |
| Current ratioi | 2.32 | 2.30 | 2.14 | 2.31 | 2.05 | 2.06 | 2.05 | 2.04 |
| Quick ratioi | 1.51 | 1.40 | 1.27 | 1.56 | 1.30 | 1.27 | 1.28 | 1.28 |
| Debt / assetsi | 39.69 | 44.76 | 52.40 | 45.75 | 38.46 | 35.69 | 33.62 | 32.52 |
| LT debt / equityi | 108.30 | 139.05 | 198.83 | 148.55 | 109.70 | 91.01 | 75.75 | 75.23 |
| Interest coveragei | 4.03 | -0.90 | -4.93 | 3.37 | 5.29 | 6.82 | 8.19 | 6.03 |
| Revenue CAGR (3Y) %i | 0.51 | 12.15 | -11.19 | -13.94 | -3.24 | 16.80 | 14.47 | 3.01 |
| Net income CAGR (3Y) %i | -- | -- | -- | -4.18 | -- | -- | 19.73 | -6.55 |
| FCF CAGR (3Y) %i | 16.14 | -- | 1.74 | -0.56 | 10.39 | 21.71 | 29.64 | 10.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 20.99 | 18.16 | 12.77 | 12.24 | 14.56 | 14.89 |
| ROA %i | 8.42 | 7.37 | 5.18 | 5.07 | 6.12 | 6.26 |
| ROIC %i | 12.66 | 11.26 | 8.20 | 8.17 | 9.54 | 9.74 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.19 | 12.98 | 10.71 | 9.57 | 10.73 | 10.84 |
| FCF / sales %i | 10.38 | 9.67 | 8.47 | 7.54 | 7.57 | 7.71 |
| Current ratioi | 1.98 | 2.00 | 1.95 | 2.04 | 2.08 | 2.02 |
| Quick ratioi | 1.20 | 1.20 | 1.21 | 1.28 | 1.30 | 1.25 |
| Debt / assetsi | 34.05 | 33.74 | 34.04 | 32.52 | 32.14 | 31.74 |
| LT debt / equityi | 76.48 | 75.38 | 77.34 | 75.23 | 71.87 | 71.04 |
| Interest coveragei | 7.16 | 6.52 | 5.37 | 6.03 | 6.90 | 7.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Completion and Production is the largest reported line at 56.04% of revenue, across 2 reported segments.
- Drilling and Evaluation follows at 43.96%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Completion and Production56.04%
Drilling and Evaluation43.96%
Quote time 2026-10-08 06:09:04 · For reference only, not investment advice and not tailored to your situation.